PrEP dominated the news at the Conference on Retroviruses and Opportunistic Infections last week in Boston, including the report of a rare failure to prevent HIV in a man taking daily Truvada ...

"We know [daily oral PrEP] works extraordinarily well if used consistently, but injectables may provide more consistent coverage," Landovitz said at a press briefing. "Having another option that's ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is ...

(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill ...

Gilead Sciences, Inc announced that it will donate Truvada for PrEP (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) to the US Centers for Disease Control and Prevention (CDC) ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Truvada clears from the bloodstream within 2 to 5 days, but may remain present in cells for 7 to 10 days. Taking it once a day is important for it to be effective. Truvada is a prescription medication ...

Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...

Prism Health provides 'holistic' HIV healthcare in South Dallas The first time Dallas resident Rafael Ruiz de Velasco heard about PrEP in 2017, it wasn’t from his doctor. It was from a dating app.